180 related articles for article (PubMed ID: 9490707)
1. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
Grass JA; Hei DJ; Metchette K; Cimino GD; Wiesehahn GP; Corash L; Lin L
Blood; 1998 Mar; 91(6):2180-8. PubMed ID: 9490707
[TBL] [Abstract][Full Text] [Related]
2. Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light.
Hei DJ; Grass J; Lin L; Corash L; Cimino G
Transfusion; 1999 Mar; 39(3):239-48. PubMed ID: 10204585
[TBL] [Abstract][Full Text] [Related]
3. Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates.
Corash L; Lin L; Wiesehahn G
Blood Cells; 1992; 18(1):57-73; discussion 74. PubMed ID: 1617193
[TBL] [Abstract][Full Text] [Related]
4. Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates.
Lin L; Londe H; Hanson CV; Wiesehahn G; Isaacs S; Cimino G; Corash L
Blood; 1993 Jul; 82(1):292-7. PubMed ID: 8324230
[TBL] [Abstract][Full Text] [Related]
5. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment.
Grass JA; Wafa T; Reames A; Wages D; Corash L; Ferrara JL; Lin L
Blood; 1999 May; 93(9):3140-7. PubMed ID: 10216113
[TBL] [Abstract][Full Text] [Related]
6. Determination of residual 4'-aminomethyl-4,5',8-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions.
Wagner SJ; White R; Wolf L; Chapman J; Robinette D; Lawlor TE; Dodd RY
Photochem Photobiol; 1993 May; 57(5):819-24. PubMed ID: 8337254
[TBL] [Abstract][Full Text] [Related]
7. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma.
Wollowitz S
Semin Hematol; 2001 Oct; 38(4 Suppl 11):4-11. PubMed ID: 11727280
[TBL] [Abstract][Full Text] [Related]
8. Elimination of potential mutagenicity in platelet concentrates that are virally inactivated with psoralens and ultraviolet A light.
Margolis-Nunno H; Robinson R; Ben-Hur E; Chin S; Orme T; Horowitz B
Transfusion; 1995 Oct; 35(10):855-62. PubMed ID: 7570917
[TBL] [Abstract][Full Text] [Related]
9. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets.
Bruchmüller I; Lösel R; Bugert P; Corash L; Lin L; Klüter H; Janetzko K
Platelets; 2005 Dec; 16(8):441-5. PubMed ID: 16287610
[TBL] [Abstract][Full Text] [Related]
10. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo.
Margolis-Nunno H; Bardossy L; Robinson R; Ben-Hur E; Horowitz B; Blajchman MA
Transfusion; 1997 Sep; 37(9):889-95. PubMed ID: 9308633
[TBL] [Abstract][Full Text] [Related]
11. Quencher-enhanced specificity of psoralen-photosensitized virus inactivation in platelet concentrates.
Margolis-Nunno H; Robinson R; Ben-Hur E; Horowitz B
Transfusion; 1994 Sep; 34(9):802-10. PubMed ID: 8091471
[TBL] [Abstract][Full Text] [Related]
12. Psoralen-mediated virus photoinactivation in platelet concentrates: enhanced specificity of virus kill in the absence of shorter UVA wavelengths.
Margolis-Nunno H; Robinson R; Horowitz B; Geacintov NE; Ben-Hur E
Photochem Photobiol; 1995 Nov; 62(5):917-22. PubMed ID: 8570732
[TBL] [Abstract][Full Text] [Related]
13. Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates.
Lin L; Wiesehahn GP; Morel PA; Corash L
Blood; 1989 Jul; 74(1):517-25. PubMed ID: 2752129
[TBL] [Abstract][Full Text] [Related]
14. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light.
Benade LE; Shumaker J; Xu Y; Chen X; Dodd RY
Transfusion; 1994 Aug; 34(8):680-4. PubMed ID: 8073484
[TBL] [Abstract][Full Text] [Related]
16. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
[TBL] [Abstract][Full Text] [Related]
17. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components.
Luban NL
Semin Hematol; 2001 Oct; 38(4 Suppl 11):34-45. PubMed ID: 11727284
[TBL] [Abstract][Full Text] [Related]
18. 4'-Aminomethyl-4,5',8-trimethylpsoralen photochemistry: the effect of concentration and UVA fluence on photoadduct formation in poly(dA-dT) and calf thymus DNA.
Oroskar A; Olack G; Peak MJ; Gasparro FP
Photochem Photobiol; 1994 Dec; 60(6):567-73. PubMed ID: 7870761
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light.
Moroff G; Wagner S; Benade L; Dodd RY
Blood Cells; 1992; 18(1):43-54; discussion 54-6. PubMed ID: 1617192
[TBL] [Abstract][Full Text] [Related]
20. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
